Docetaxel-rechallenge in castration-resistant prostate cancer: defining clinical factors for successful treatment response and improvement in overall survival.
第一作者:
Christian,Thomas
第一单位:
Department of Urology, University of Mainz, Langenbeckstraße 1, 55131, Mainz, Germany. thomasch@uni-mainz.de.
作者:
医学主题词
老年人(Aged);雄甾烯类(Androstenes);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨肿瘤(Bone Neoplasms);无病生存(Disease-Free Survival);随访研究(Follow-Up Studies);促性腺素释放激素(Gonadotropin-Releasing Hormone);人类(Humans);淋巴转移(Lymphatic Metastasis);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);睾丸切除术(Orchiectomy);前列腺特异抗原(Prostate-Specific Antigen);前列腺切除术(Prostatectomy);再治疗(Retreatment);回顾性研究(Retrospective Studies);存活率(Survival Rate);紫杉烷类(Taxoids)
DOI
10.1007/s11255-018-1963-1
PMID
30120678
发布时间
2019-01-25
- 浏览8
International urology and nephrology
1821-1827页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



